Table 1 Demographic and baseline characteristics
|  | Low dose group (N = 32) | High dose group (N = 32) | Total (N = 64) |
|---|---|---|---|
Age | |||
 Average age | 35.5 (±13.0) | 31.4 (±11.1) | 33.5 (±12.2) |
 18–59 years n (%) | 31 (96.88%) | 31 (96.88%) | 62 (96.88%) |
 ≥60 years n (%) | 1 (3.13%) | 1 (3.13%) | 2 (3.13%) |
Gender | |||
 Male n (%) | 8 (25.00%) | 3 (9.38%) | 11 (17.19%) |
 Female n (%) | 24 (75.00%) | 29 (90.63%) | 53 (82.81%) |
Number of previous COVID-19 vaccinations | |||
 Two dose n (%) | 11 (34.38%) | 10 (31.25%) | 21 (32.81%) |
 Three dose n (%) | 21 (65.63%) | 22 (68.75%) | 43 (67.19%) |
Average vaccination interval | |||
 Months | 15.0 (9.2–20.5) | 15.3 (9.3–20.7) | 15.2 (9.2–20.7) |
